| RCC | Renal Cell Carcinoma |
| mRCC | Metastatic Renal Cell Carcinoma |
| ICI | Immune Checkpoint Inhibitors |
| CRN | Cytoreductive Nephrectomy |
| CARMENA | Cancer du Rein Metastatique Nephrectomie et Antiangiogéniques |
| SURTIME | Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 and PD-L2 | Programmed cell death protein ligand 1 and 2 |
| CTLA4 | Cytotoxic T-lymphocyte associated protein 4 |
| NCCN | National Comprehensive Cancer Network |
| TKI | Tyrosine Kinase Inhibitors |
| VEGFR | Vascular Endothelial Growth Factor Receptor Inhibitors |
| IMDC | International Metastatic RCC Database Consortium |
| BMI | Body Mass Index |
| HTN | Hypertension |